Evolving the standard of care

Our dedicated research team pursues an aggressive research agenda aimed at evolving the standard of care.
Image of physicians and researchers discussing next to a computer

Our research includes:

  • Prediction of AF recurrence after cryoballoon pulmonary vein isolation using 30-day continuous full disclosure mobile cardiac telemetry.
  • Comparison of implantable loop monitors.
  • Cardio-surveillance of cancer patients undergoing immune checkpoint blockade.
  • Digital health embedded trial, post-CABG trial.
  • Predictors of atrial fibrillation, bradyarrhythmias, and ventricular arrhythmias in physical activity.
  • Monitoring of COVID-19 patients in clinical trials using off-label anti-virals.

In addition, we have authored multiple poster presentations:

Cover of AF Epidemic White paper
New research offers guidance for the atrial fibrillation epidemic

Mobile cardiac monitoring: Which device is the right choice?

Cover of Increasing Diagnostic Yield (DY) of Bradyarrhythmia white paper
Increasing Diagnostic Yield (DY) of Bradyarrhythmia

New research shows continuous, full-disclosure telemetry monitoring significantly increased DY compared to patch and Holter methods.

Cover of New research shows micro-AF episodes are early indicators of clinical AF white paper
New research shows micro-AF episodes are early indicators of clinical AF

Study recommends extending cardiac monitoring for 72 hours if micro-AF is detected.